David Risinger, CFA

David Risinger, CFA is a Senior Managing Director and Senior Research Analyst at Leerink Partners covering Diversified Biopharmaceuticals.

Prior to joining the Firm in 2022, Mr. Risinger served as Head of U.S. Major and Specialty Pharmaceuticals Equity Research at Morgan Stanley & Co. Prior to Morgan Stanley, Mr. Risinger was Head of Global Healthcare Research and Senior U.S. Pharmaceutical Analyst at Merrill Lynch & Co. He began his Wall Street career at Dillon, Read & Co. Mr. Risinger has been a top-ranked analyst by Institutional Investor for decades, including achieving Runner-Up rankings in both Major Pharmaceuticals and Specialty Pharmaceuticals in 2021.

Mr. Risinger earned a B.A. in Political Science from Bucknell University and holds the Chartered Financial Analyst designation.